Overview
Lincoln Nadauld is an Oncologist practicing medicine in Ogden, Utah.
Dr. Nadauld is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pleuropulmonary Blastoma, Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Bone Marrow Aspiration.
Dr. Nadauld is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 1 clinical trial. Dr. Nadauld is currently accepting new patients.
Graduate Institution
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4403 Harrison Blvd Ste 2855, Ogden, UT 84403
201 W Layton Pkwy Ste 2A, Layton, UT 84041
1380 E Medical Center Dr, Saint George, UT 84790
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Huntsman Cancer Institute, Hematology-Oncology
Neeraj Agarwal is an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Agarwal is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Orchiectomy, and Tissue Biopsy. Dr. Agarwal is board certified in American Board Of Internal Medicine. Dr. Agarwal is currently accepting new patients.
Pediatric Bone Marrow Transplant
Michael Pulsipher is a Hematologist and an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Pulsipher is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics.
Hematology-Oncology - Nielsen Rehabilitation Hospital
Ignacio Garrido is an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Garrido is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatoblastoma, and Pancreatectomy. Dr. Garrido is board certified in American Board Of Internal Medicine. Dr. Garrido is currently accepting new patients.
Frequently Asked Questions about Dr. Lincoln Nadauld
How do I make an appointment with Dr. Lincoln Nadauld?
You can book an appointment with Dr. Lincoln Nadauld by calling their office at 801-387-7150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lincoln Nadauld a top-rated expert for Neuroendocrine Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lincoln Nadauld is classified as an Distinguished expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lincoln Nadauld specialize in?
While Dr. Lincoln Nadauld is a Oncology, they have specific expertise in Neuroendocrine Tumor, Pleuropulmonary Blastoma, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Lincoln Nadauld participate in research or clinical trials?
Yes. Dr. Lincoln Nadauld has published 57 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Dr. Lincoln Nadauld's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lincoln Nadauld accept my insurance?
Dr. Lincoln Nadauld accepts most major insurance plans, including Aetna and BridgeSpan. We recommend calling the office directly at 801-387-7150 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Neuroendocrine TumorDr. Nadauld isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colorectal CancerDr. Nadauld isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Nadauld isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Nadauld isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Nadauld isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Nadauld isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Appendix CancerDr. Nadauld isExperienced. Learn about Appendix Cancer.
- Bladder CancerDr. Nadauld isExperienced. Learn about Bladder Cancer.
- Bone Marrow AspirationDr. Nadauld isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Nadauld isExperienced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Nadauld isExperienced. Learn about Chromophobe Renal Cell Carcinoma.